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ABSTRACT  
Acute kidney injury (AKI) indicates its abrupt deterioration and is defined as an increase in serum creatinine more than the baseline by > 26 
umol/L within 48 hours or > 50% within 1 week.  The latter since glomerular failure is the life-threatening one with: (a) uremic intoxication, (b) 
water and salt retention with fluid overload, and (c) potassium accumulation with cardiac arrest.  The etiology can be pre-renal, post-renal or 
intrinsic.  Diagnosis is established by history of new insults, physical examination for hydration status, systemic stability and manifestations of 
autoimmune diseases/infections as well as an initial laboratory testing for renal function (serum creatinine, electrolytes and urine routine) and 
kidney ultrasound.  Additional specific tests are indicated to assess etiology of AKI and its associated co-morbid conditions that interacts with 
its management.  Severity of AKI ranges from mild (stage 1) to advanced (stage 5) that requires dialytic support.  Moreover, it depends on the 
type and duration of the insult.  Prognosis depends on etiology of AKI, its co-morbid conditions and the timely interventions by the supportive 
medical team.   
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INTRODUCTION 
The kidneys are 2 bean-shaped, 10-12 cm organs, that lies 
posteriorly and extraperitonealy in the abdomen on both 
sides of the vertebral column.  Beneath its fibrous capsule is 
a 1-2 cm cortex that contains 85% of the glomeruli.  The 
kidneys receive 25% of the cardiac output to be cleared from 
its waste products (uremic toxins) and to maintain body 
homeostasis i.e. adjustment of its metabolic changes in body 
water, electrolytes, osmolality and acid-base.  Each kidney is 
made up of 1-1.5 million functional units called nephrons 
(Fig. 1).  The nephron receives blood via afferent arteriole to 
form a plexus of capillaries that has lost their muscular wall 
for filtration.  The latter is the glomerulus via which fluids 
sieve to a collecting capsule called Bowman’s capsule.  Most 
of the filtered fluid and its electrolytes are being reabsorbed 
in the proximal convoluted tubules, ascending limb of Henle, 
distal convoluted tubule and collecting duct.  Sixty% of 
filtered sodium is being reabsorbed in the PCT, 20% in limb 
of Henle and 10% in distal tubule.  In the latter segment ½ is 
in exchange with potassium under the effect of aldosterone.  
At the same site, calcium and magnesium are reabsorbed 
under effect of parathyroid hormone.  In the terminal part of 
the nephron water is being reabsorbed by antidiuretic 
hormone to maintain body osmolality.  Acid base balance of 
the kidney is mainly done in the DCT by exchange of sodium 
and potassium with hydrogen ions to regenerate body 
bicarbonate to maintain blood pH 1.  The interstitium 
synthesize erythropoietin in response to low oxygenation of 
the peritubular cells.  Moreover, the cholecalciferol formed 
by ultraviolet effect on subcutaneous cholesterol substrates 
gets activated in the liver in 25 position to form 25 
hydroxycholecalciferol which ultimately needs the kidney to 
add another hydroxyl group in the alpha position to form the 
100 times more active form of vitamin D (1, 25 
dihydroxycholecalciferol) 2.  The macula densa are modified 
cells in the DCT which is in contact with the afferent arteriole 
forming juxtraglomerular apparatus.  The low pressure in 
the afferent arteriole in hypotensive states and the low salt 
content delivered in case of dehydration lead to release of 
Renin which forms ultimately angiotensin II to cause 
vasoconstriction and raise blood pressure and aldosterone to 
prevent stimulate more sodium reabsorption in the 
subsequent segments of DCT to maintain intravascular 
volume 3.  Angiotensin II generate local prostaglandins in the 
kidney leading to dilation of the afferent arteriole and 
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constriction of the efferent one leading to more hydrostatic 
pressure in the glomerulus to maintain glomerular filtration 
rate and clearance of wastes of metabolism.  Such changes 
are referred to as autoregulation and are intended to adjust 
blood pressure, sodium water content under physiological 
states i.e. few hours fast 4.  
 
 
Figure 1: Diagram of the nephron segments and its juxtaglomerular apparatus 
 
 
RENAL FAILURE 
Renal failure (RF) implies failure of function of; (a) 
glomeruli, (b) tubules, and interstitium.  However, (a) 
interstitial failure can be corrected by erythropoietin and 
calcium/active forms of vitamin D, (b) tubular defects are 
rarely life threatening except for severe Bartter’s syndrome 
and distal RTA.  On the other hand, the only life threating 
failure is the glomerular one with: (a) uremic intoxication, 
(b) water and salt retention with fluid overload, and (c) 
potassium accumulation with cardiac arrest.  Hence, extent 
of glomerular failure which is measured by decrement in 
glomerular filtration rate (GFR) was used to express kidney 
failure.  GFR is the amount of fluid filtered in 1 minute.  
Normally it is 80-120 ml/min.  Since the average is 100 
ml/min; changes in function can be expressed as changes in 
100%.   
ASSESSMENT OF KIDNEY FUNCTION 
True estimate of GFR is done by a substance that is neither 
secreted nor excreted.  The latter apply to inulin and 
isothalamate.  The Inulin and PAH clearance requires 
injection of those substances then 24 hour urine collection 
which is not practical for humans 5.  GFR can be assessed 
using chromium-51 and technetium-99 nuclear scans yet it 
is available only in specialized centers 6.  In normal 
conditions; serum creatinine is produced from the muscle at 
a steady state.  It can be easily measured and it is the most 
practical way to test kidney function.  However, since 
secreted by the kidney tubules, its relationship with kidney 
function is not linear 7.  In early failure, serum creatinine 
does not rise above higher limit of normal unless 50% of 
kidney function is lost.  Such rise, in urea and creatinine 
(nitrogenous products) in blood, is referred to as azotemia.  
AUTOREGULATION IN HEALTH AND DISEASE 
Due to autoregulation; any decrease in kidney function is 
compensated by an increment of 10%.  Hence, when stages 
of kidney failure were described; stage 3 (azotemia) starts if 
GFR is < 60% rather than the actual 50% of kidney failure.  
On the other hand; stage 4 if GFR < 30 % defines a stage 
where the use of ACEI/ARB is contraindicated.  Those drugs 
abolish the 10% hyperfiltration (due to efferent arteriolar 
constriction) and bring patients to stage 5 which < 15%.  The 
latter stage is uremic i.e. symptomatic renal failure and 
hence indicates dialysis.  Similar effect if NSAID abolish the 
dilatation of afferent arteriole by blocking prostacyclins 
induced by angiotensin II activation.  
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DEFINITIONS OF RF 
To avoid using follow up measurements of creatinine 
clearance and the increment of serum creatinine above 
normal range; changes in the patient’s own serum creatinine 
can be used to detect an acute change if function.  Hence, an 
increment > 26 umol/L over 48 hours or > 50% decrease 
CrCl was labeled as an Acute RF or acute kidney injury (AKI) 
8.  
ETIOLOGY OF AKI 
The causes of AKI can be divided into three categories (Fig. 
2).  They include; prerenal (decreased perfusion), 
intrinsic renal (caused by a damage to the kidney itself), and 
postrenal (caused by obstruction to urine excretion). 
  
 
Figure 2: Algorithm for diagnosis of the etiology of acute kidney injury 
 
 
EPIDEMIOLOGICAL PROFILE OF AKI 
AKI is a major world-wide health problem with its high 
incidence rate among hospitalized patients, mortality rate 
and cost of treatment.  In our area, a prospective study 
conducted over 18 months disclosed features of its 
epidemiological profile 9.  The calculated annual incidence of 
AKI was 14.7 per 100,000 populations.  Cases of community 
acquired AKI were double the hospital-acquired one.  Sepsis, 
urinary tract obstruction, volume depletion and glomerular, 
diseases were the most frequent causes of community 
acquired AKI while drug-induced, volume depletion and 
sepsis dominated the hospital one.   The prognosis of AKI 
depended on 2 major factors; (a) type of etiological insult 
and the presence of predisposing co-morbid conditions.  
Multiple insults, though common, did not affect mortality 
rate.  The overall mortality rate was only 14% yet sepsis-
induced AKI had 36% cause-specific mortality.   
 
MANAGEMENT OF AKI 
Management indicates knowledge on: 
(a) Renal derangement, (b) AKI and its etiology, (c) chronic 
RF and its previous stage, (d) co-morbid condition, (d) 
interaction between diagnostic tests, drug therapy, RF and 
co-morbid conditions.  Integration of clinical data as well as 
laboratory, radiological and serological tests are essential for 
diagnosis and management. 
Diagnosis of renal derangement: 
Practically; 3 elements should be tested to assess for RF; (a) 
serum creatinine, (b) urine routine and microscopy, and (c) 
kidneys ultrasound.  A single abnormality indicates disease.  
Urine tests for osmolality and sodium are not useful.  Urinary 
sodium is high if associated with chronic RF.  Urine 
proteinuria > 2 g/day indicates glomerular etiology and 
absence rule it out. 
 
Pre-renal Intrinsic Post-renal (obstruction)
1- External fluid loss: 1- Tubular: crystals & myeloma casts
bleeding, excessive diuresis & losses from gut or skin 2- Urinary tract: 
2- Translocation of intravascular volume:
Pancreatitis, Peritonitis, ileus, nephrotic crisis
3- Poor cardiac output:
LV dysfunction, valvular and pericardial disease
4- Decreased peripheral vascular resistance:
sepsis & drugs
5- Excessive local vasoconstriction:
Hypercalcemia & hepatorenal syndrome
6- Blocking of dilating prostaglandins:
NSAID in CRF or ACEI/ARB in renovascular or stage 4,5 RF
Both in: decrease effective intravascular volume (pre-renal states)
Tubulointerstitial Glomerular Vascular
A- Acute tubular necrosis: 1- Proliferative & Crescentic GN A- Large vessel:
A- Ischemic ATN: (severe & prolonged pre-renal state) 2- If systemic manifestations: I- Bilateral renal artery 
B- Nephrotoxic ATN: SLE & vasculitis (stenosis, thrombosis, emboli)
Drugs: aminoglycosides, amphotericin B, Cis-platinum II- Bilateral renal vein thrombosis
Chlorinated organic solvents: B- Small vessel:
Ethylene glycol, carbon tetra, herbicides 1- Vasculitis (PAN)
Heavy metals: 2- Malignant hypertension
Organic lead & mercury 3- Scleroderma
Radiocontrast media: 4- Cholesterol atheroembolism
Cell-lysis proteins:
Rhabdomyelosis & hemolysis
B- Acute interstitial nephritis:
Drugs, infections & autoimmune
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Diagnosis of setting of AKI:  
If abnormal RF; diagnosis of AKI, chronic RF or AKI on top of 
chronic disease should be defined vas shown in the 
algorithm in (Figure 1).  Aids in diagnosis include: 
1- History & physical examination. 
2- Ultrasound for kidney size& shape since any abnormal 
size or shape indicates chronicity except for 
hydronephrosis. 
3- Renal osteodystrophy (not 
hypocalcemia/hyperphosphatemia or high PTH since 
may develop within 2 weeks. 
4- Kidney biopsy if needed especially in interstitial 
nephritis, glomerular disease and vasculitis.  
Management of patient with renal failure: 
As shown in Figure 1; return to normal can be established 
with treatment of acute RF.  Despite the presence of chronic 
disease viz. diabetic glomerulosclerosis; treatment of acute 
insult such as dehydration from uncontrolled hyperglycemia, 
sepsis, obstruction by a papillary necrosis or an incidental 
drug side-effect, is rewarding and improves stage of RF.  
Moreover, early intervention, in the initiation phase, is 
essential to clear the insult, decrease the need for supportive 
dialysis and prevent the complications.   The latter 
complications can be associated with RF, worsening of co-
morbid conditions, dialysis technique and kidney loss.  The 
latter phenomenon is associated with delay in diagnosis of 
autoimmune diseases (glomerulonephritis and vasculitis) 
and/or inadequate therapy 10.  Three months is the limited 
time factor in correction of acute RF and establishment of a 
chronic damage 11.  Uremic patients with acute RF are 
supported with dialysis till correction of the acute 
component.  If did not improve; will need renal replacement 
therapy (RRT) in the form of maintenance dialysis or future 
kidney transplantation if fit.  If by the end of 3 months; stage 
4 RF; patients should have dialysis access (preferably fistula) 
and transplant work up. 
Dialytic support: 
Initially, hemodialysis was provided for those with traumatic 
rhabdomyelosis during World War II by William Kolff 12.  
Subsequently, the technique has improved with smaller 
filters, better machines that resulted in less dialysis duration 
and better patient’s safety.  Initially, peritoneal dialysis was 
preferred for uremic patients with unstable cardiovascular 
status due to sepsis with/without hypotension and those 
with cardiac disease including myocardial infarctions13.  The 
technique of blood purification has improved dramatically in 
the past 20 years with the introduction of high-flux filters 
and continuous veno-venous hemodiafilteration 14.  The 
latter is a slow yet effective technique, even for unstable 
patients, and had replaced acute peritoneal therapy.  
However, it is expensive and needs continuous monitoring 
which limited it to specialized hospital-based ICU, CCU and 
renal units 15.  
 
Prognosis of acute RF: 
Prompt and proper correction of acute pre- and post-renal 
insults as well as tubulointerstitial disease is rewarding.  
Unfortunately, and as has been stated previously, kidney 
survival is limited with maltreated autoimmune and vascular 
diseases.  
In conclusion; acute RF is a common condition, frequently 
encountered in both community practice and hospital 
inpatients. While it remains a heterologous condition, early 
diagnosis and prompt establishment of therapy is corner 
stones in kidney and patients’ survival.   
REFERENCES: 
1. Lote, Christopher J. (2012). Principles of Renal Physiology, 5th 
edition. Springer. p. 21. 
2. Mukoyama M, Nakao K. Hormones of the kidney. In: Melmed S, 
Conn PM, editors. Endocrinology: Basic and clinical 
Principles. 2nd ed. Totowa, New Jersey: Humans Press; 2005. 
pp. 353–66. 
3. Komlosi P, Fintha A, Bell PD. Current mechanisms of macula 
densa cell signalling.  Acta Physiologica Scandinavica 
2004; 181:463–469.  
4. Guyton and Hall, Textbook of Medical Physiology, 13th 
Edition.  
5. Rose GA.  Measurment of glomerular filtration rate by inulin 
clearance without urine collection.  BMJ 1969; 2:91-93.  
6. Murray AW, Barnfield MC, Waller ML, Telford T, Peters AM.  
Assessment of Glomerular Filtration Rate Measurement with 
Plasma Sampling: A Technical Review. J Nucl Med 
Technol 2013; 41:67-75.  
7. Ganong (2016). "Renal Function & Micturition". Review of 
Medical Physiology, 25th ed. McGraw-Hill Education. p. 677. 
8. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury 
Network: report of an initiative to improve outcomes in acute 
kidney injury. Crit Care 2007; 11:R31. 
9. El-Reshaid K, Kapoor M, Johny KV and Sugathan TN.  Acute 
renal failure in Kuwait, a prospective study.  J Trop Med 
Hygiene 1993; 96:323-329. 
10. United States Renal Data System. 2018 USRDS annual data 
report: epidemiology of kidney disease in the United States. 
Bethesda, MD: National Institutes of Health, National Institute 
of Diabetes and Digestive and Kidney Diseases; 2018. 
11. Kidney Disease: Improving Global Outcomes (KDIGO) Acute 
Kidney Injury Work Group. KDIGO clinical practice guideline 
for acute kidney injury. Kidney Int 2012; 2(suppl):1-138. 
12. John Francis Maher (1 January 1989).  Replacement of renal 
function by dialysis: A text book of dialysis. Springer p: 33.  
13. Ash SR, Bever SL.  Peritoneal dialysis for acute renal failure: 
the safe, effective, and low-cost modality.  Adv Ren Replace 
Ther 1995; 2:160-163. 
14. Bellomo, Ronco C.  Continuous hemofiltration in the intensive 
care unit.  Crit Care 2000; 4:339-345. 
15. Permuzic V, Basic-Jukic N, Jelakovic B, Kes P.  Differences in 
CVVH vs. CVVHDF in the management of sepsis-induced acute 
renal injury in critically ill patients.  J Artif Organs 2017; 
20:326-334. 
 
 
